Apolipoprotein(a) isoforms and coronary heart disease in men A nested case-control study

Atherosclerosis

Volumn 132, Issue 1, 1997, Pages 77-84

  Klausen, Ib Christian ^a   Sjøl, Anette ^b   Hansen, Peter Steen ^a   Gerdes, Lars Ulrik ^a   Møller, Lars ^b   Lemming, Lone ^a   Schroll, Marianne ^b   Faergeman, Ole ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Glostrup Population Studies   (Denmark)

Author keywords

Apolipoprotein B; Apolipoprotein(a); Cholesterol; Coronary heart disease; Lipoprotein(a); Myocardial infarction

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 6; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; APOLIPOPROTEINS; APOPROTEIN(A); CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; CORONARY DISEASE; DENMARK; DISEASE SUSCEPTIBILITY; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MOLECULAR WEIGHT; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 0030851240     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00071-3     Document Type: Article

References (39)

1. Renninger W, Wendt GG, Nawrocki P, Weigand H. Beitrag zur Problematik des Lp-systems. Humangenetik 1965;1:658-667.
2. Berg K, Dahlen G, MH. Lp(a) lipoprotein and pre-beta-lipoprotein in patients with coronary heart disease. Clin Genet 1974;6:230-235.
3. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540-2544.
4. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein(a) is an independent risk factorfor myocardial infarction at a young age. Clin Chem 1990;36:20-23.
5. Armstrong V W, Cremer P, Eberle E, Manke A, Schulze F, Wieland Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986;62:249-257.
6. Kostner G, Avogaro P, Cazzalato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981;38:51-61.
7. Sandholzer C, Saha N, Kark, JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G. Apo(a) isoforms predict risk for coronary heart disease. A study of six poulations. Arterioscler Thromb 1992;12:1214-1226.
8. Rosengren A, Wilhelmsen L, Erikeson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men. Br Med J 1990;301:1248-1251.
9. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992;69:1251-1254.
10. Schaefer EJ, Lamon-Fava S, Jenner JL, NcNamara J, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy RI. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid research clinics coronary primary prevention trial. JAMA 1994;271:999-1003.
11. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, Seidel D. Lipoprotein (Lp(a)) as a predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Göttingen risk incidence and prevalence study (GRIPS). Eur J Clin Invest 1994;24:444-453.
12. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated Lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-1184.
13. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PWF, Schaefer EJ, Castelli WP. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 1996;276:544-548.
14. Kraft HG, Lingenhel A, Kochl S, Hoppichler F, Kronenberg F, Abe A, Muhlberger V, Schonitzer D, Utermann G. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vase Biol 1996;16:713-719.
15. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Manttari M, Manninen V, Huttunen JK. Lipoprotein(a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991;89:59-67.
16. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993;270:2195-2199.
17. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi, Karvonen M, Toumiletho J, Salonen JT, Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106:9-19.
18. Nieminen MS, Mattila KJ, Aalto-Setala K, Kuusi T, Kontula K, Kauppinen-Maklin R, Ehnholm C, Jauhiainen M, Valle M, Taskinen M-R. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb 192;12:58-69.
19. Kwiterovich PO, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA. Comparison of plasma levels of alipopoproteins B and Al, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 1992;69:1015-1021.
20. Simons L, Friedlander Y, Simons J, McCallum J. Lipoprotein(a) is not associated with coronary heart isease in the elderly:cross-sectional data from the Dubbo study. Atherosclerosis 1993;99:87-95
21. Barnathan ES (editorial). Has Lipoprotein 'Little' (a) shrunk? JAMA 1993;270:2224-2225.
22. Gurewich V, Mittleman M (editorial). Lipoprotein(a) in coronary heart disease-is it a risk factor after all? JAMA 1994;271:1025-1026.
23. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) Glycoprotein Phenotypes. Inheritance and relation to Lp(a) lipoprotein concentration in plasma. J Clin Invest 1987;80:458-465.
24. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs H. Molecular basis of apolipoprotein(a) isoform heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991;87:2153-2161.
25. Kraft HG, Kochel S, Menzel HJ, Sandholzer C, Utermann G. A transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992;90:220-230.
26. McLean JW, Tomlinson JE, Kuang W-j, Eaton DL, Chen KY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;300:132-37.
27. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989;78:145-150.
28. Rothman KJ. Modern epidemiology. Boston/Toronto: Little, Brown and Company, 1986.
29. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoproteins(a), A1 and B and parental history in men with early onset ischemic heart disease. Lancet 1988;i:1070-1073.
30. Srinivasan SR, Dahlen G, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. Bogalusa heart study. Circulation 1991;84:160-167.
31. Klausen IC, Beisiegel U, Menzel MJ, Rosseneu M, Nicaud V, Faergeman O, on behalf of the EARS group. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS study. Arterioscler Thromb Vase Biol 1995;15:1001-1008.
32. Sjøl A, Grunnet K, Schroll M. Secular trends in serum cholesterol, high density lipoproteins and triglycerides 1964-1987. Int J Epidemiol 1991;20:105-113.
33. Klausen IC, Gerdes LU, Schmidt EB, Dyerberg J, Faergeman O. Differences in apolipoprotein(a) polymorphism in west Greenland Eskimos and Caucasian Danes. Hum Genet 1992;89:384-388.
34. Kraft HG, Dieplinger H, Hoye E, Utermann G. Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis 1988;8:212-216.
35. Breslow NE, Day NE. Statistical methods in cancer research, Volume 1-The analysis of case-control studies. Lyon: IARC Scientific publications no. 32, 1980.
36. Marenberg ME, Risch N, Berkman LF, Floderus B, De Faire U. Genetic Susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-1046.
37. Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE' Boerwinkle E, Hillis LD, Hobbs HH. No association between plasma Lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vase Biol 1995;15:850-855.
38. WHO. Regional office for Europe: Report of the fifth working group. Copenhagen, 1971.
39. Kronenberg F, Trenkwalder E, Dieplinger H, Utermann G. Lipoprotein(a) in stored plasma and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol 1996;16:1568-1572.